CoChat

Cognitive Impairment in Older Adults

Pérez Palmer, Nicolás, Trejo Ortega, Barbara, Joshi, Pallavi · 2022 · Psychiatric Clinics of North America
Cited by 177

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Cognitive impairment and dementia affect dozens of millions of people worldwide and cause significant distress to patients and caregivers and a financial burden to families and health care systems. Careful history-taking, cognitive and physical examination, and supplemental neuroimaging and fluid-based biomarkers can accurately diagnose neurocognitive disorders. Management includes non-pharmacological and pharmacological treatments tailored to the etiology and to the individual.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.psc.2022.07.010

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 78

  1. Anderson, 2019, State of the science on mild cognitive impairment (MCI), CNS Spectr, 24, 78, 10.1017/S1092852918001347 · DOI · Paper page
  2. Sanford, 2017, Mild cognitive impairment, Clin Geriatr Med, 33, 325, 10.1016/j.cger.2017.02.005 · DOI · Paper page
  3. Kramarow, 2019, Dementia mortality in the United States, 2000-2017, Natl Vital Stat Rep, 68, 1
  4. 2021, 2021 Alzheimer’s disease facts and figures, Alzheimers Dement J Alzheimers Assoc, 17, 327, 10.1002/alz.12328 · DOI · Paper page
  5. Akarsu, 2019, Depression in carers of people with dementia from a minority ethnic background: Systematic review and meta-analysis of randomised-controlled trials of psychosocial interventions, Int J Geriatr Psychiatry, 34, 790, 10.1002/gps.5070 · DOI
  6. Arvanitakis, 2019, Diagnosis and management of dementia: review, JAMA, 322, 1589, 10.1001/jama.2019.4782 · DOI · Paper page
  7. Hugo, 2014, Dementia and cognitive impairment: epidemiology, diagnosis, and treatment, Clin Geriatr Med, 30, 421, 10.1016/j.cger.2014.04.001 · DOI · Paper page
  8. Hogan, 2016, The prevalence and incidence of dementia with Lewy bodies: a systematic review, Can J Neurol Sci J Can Sci Neurol, 43, S83, 10.1017/cjn.2016.2 · DOI · Paper page
  9. Leroy, 2021, Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network, Alzheimers Res Ther, 13, 19, 10.1186/s13195-020-00753-9 · DOI
  10. Young, 2018, Frontotemporal dementia: latest evidence and clinical implications, Ther Adv Psychopharmacol, 8, 33, 10.1177/2045125317739818 · DOI · Paper page
  11. Vann Jones, 2014, The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies, Psychol Med, 44, 673, 10.1017/S0033291713000494 · DOI · Paper page
  12. Zaccai, 2005, A systematic review of prevalence and incidence studies of dementia with Lewy bodies, Age Ageing, 34, 561, 10.1093/ageing/afi190 · DOI · Paper page
  13. Aarsland, 2005, A systematic review of prevalence studies of dementia in Parkinson’s disease, Mov Disord Off J Mov Disord Soc, 20, 1255, 10.1002/mds.20527 · DOI · Paper page
  14. Svenningsson, 2012, Cognitive impairment in patients with Parkinson’s disease: diagnosis, biomarkers, and treatment, Lancet Neurol, 11, 697, 10.1016/S1474-4422(12)70152-7 · DOI · Paper page
  15. Kane, 2018, Clinical prevalence of Lewy body dementia, Alzheimers Res Ther, 10, 19, 10.1186/s13195-018-0350-6 · DOI · Paper page
  16. Avila, 2021, Education differentially contributes to cognitive reserve across racial/ethnic groups, Alzheimers Dement, 17, 70, 10.1002/alz.12176 · DOI · Paper page
  17. Elkana, 2020, Is the cutoff of the MoCA too High? longitudinal data from highly educated older adults, J Geriatr Psychiatry Neurol, 33, 155, 10.1177/0891988719874121 · DOI
  18. Cao, 2012, Comparison of the saint louis university mental status examination, the mini-mental state examination, and the montreal cognitive assessment in detection of cognitive impairment in chinese elderly from the geriatric department, J Am Med Dir Assoc, 13, 626, 10.1016/j.jamda.2012.05.003 · DOI
  19. Cummings-Vaughn, 2014, Veterans affairs saint louis university mental status examination compared with the montreal cognitive assessment and the short test of mental status, J Am Geriatr Soc, 62, 1341, 10.1111/jgs.12874 · DOI
  20. Silva, 2018, Olfactory dysfunction in Alzheimer’s disease Systematic review and meta-analysis, Dement Neuropsychol, 12, 123, 10.1590/1980-57642018dn12-020004 · DOI
  21. Carnemolla, 2020, Olfactory dysfunction in frontotemporal dementia and psychiatric disorders: a systematic review, Neurosci Biobehav Rev, 118, 588, 10.1016/j.neubiorev.2020.08.002 · DOI
  22. Gauthier, 2010, Management of behavioral problems in Alzheimer’s disease, Int Psychogeriatr, 22, 346, 10.1017/S1041610209991505 · DOI · Paper page
  23. Johnson, 2013, Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association, Alzheimers Dement J Alzheimers Assoc, 9, e-1
  24. Masters, 2015, Alzheimer’s disease, Nat Rev Dis Primer, 1, 15056, 10.1038/nrdp.2015.56 · DOI · Paper page
  25. Zhu, 2015, Rate of early onset Alzheimer’s disease: a systematic review and meta-analysis, Ann Transl Med, 3, 38
  26. Rentería, 2020, Genetic testing for Alzheimer’s disease: trends, challenges and ethical considerations, Curr Opin Psychiatry, 33, 136, 10.1097/YCO.0000000000000573 · doi:10.1097/yco.0000000000000573
  27. Jellinger, 2010, Is there pure vascular dementia in old age?, J Neurol Sci, 299, 150, 10.1016/j.jns.2010.08.038 · DOI
  28. Reed, 2007, Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease, Brain J Neurol, 130, 731, 10.1093/brain/awl385 · DOI · Paper page
  29. Graff-Radford, 2019, Vascular cognitive impairment, Contin Minneap Minn, 25, 147
  30. Baezner, 2008, Association of gait and balance disorders with age-related white matter changes: the LADIS study, Neurology, 70, 935, 10.1212/01.wnl.0000305959.46197.e6 · DOI · Paper page
  31. Schmidt, 2012, White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations, Stroke, 43, 2643, 10.1161/STROKEAHA.112.662593 · DOI · Paper page
  32. Salmon, 2007, Neuropsychology of cortical versus subcortical dementia syndromes, Semin Neurol, 27, 7, 10.1055/s-2006-956751 · DOI · Paper page
  33. Charidimou, 2012, Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis, Stroke, 43, 2324, 10.1161/STROKEAHA.112.657759 · DOI · Paper page
  34. Revesz, 2009, Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies, Acta Neuropathol (Berl), 118, 115, 10.1007/s00401-009-0501-8 · DOI · Paper page
  35. Tomidokoro, 2010, Iowa variant of familial Alzheimer’s disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits, Am J Pathol, 176, 1841, 10.2353/ajpath.2010.090636 · DOI
  36. Zhang-Nunes, 2006, The cerebral beta-amyloid angiopathies: hereditary and sporadic, Brain Pathol Zurich Switz, 16, 30, 10.1111/j.1750-3639.2006.tb00559.x · DOI · Paper page
  37. Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  38. Montembeault, 2018, Clinical, anatomical, and pathological features in the three variants of primary progressive aphasia: a review, Front Neurol, 9, 692, 10.3389/fneur.2018.00692 · DOI · Paper page
  39. Villarejo-Galende, 2017, Amyloid pet in primary progressive aphasia: case series and systematic review of the literature, J Neurol, 264, 121
  40. Chow, 1999, Inheritance of frontotemporal dementia, Arch Neurol, 56, 817, 10.1001/archneur.56.7.817 · DOI · Paper page
  41. Goldman, 2005, Comparison of family histories in FTLD subtypes and related tauopathies, Neurology, 65, 1817, 10.1212/01.wnl.0000187068.92184.63 · DOI · Paper page
  42. Seelaar, 2008, Distinct genetic forms of frontotemporal dementia, Neurology, 71, 1220, 10.1212/01.wnl.0000319702.37497.72 · DOI · Paper page
  43. Sezgin, 2019, Parkinson’s disease dementia and Lewy body disease, Semin Neurol, 39, 274, 10.1055/s-0039-1678579 · DOI · Paper page
  44. Hamilton, 2012, Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy Bodies, Am J Geriatr Psychiatry, 20, 773, 10.1097/JGP.0b013e31823033bc · DOI
  45. Postuma, 2009, Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder, Neurology, 72, 1296, 10.1212/01.wnl.0000340980.19702.6e · DOI · Paper page
  46. Day, 2022, Aducanumab use in symptomatic Alzheimer disease evidence in focus: a report of the AAN guidelines subcommittee, Neurology, 98, 619, 10.1212/WNL.0000000000200176 · DOI · Paper page
  47. Cooper, 2013, Treatment for mild cognitive impairment: systematic review, Br J Psychiatry J Ment Sci, 203, 255, 10.1192/bjp.bp.113.127811 · DOI · Paper page
  48. Raschetti, 2007, Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials, PLoS Med, 4, e338, 10.1371/journal.pmed.0040338 · DOI · Paper page
  49. Cheng, 2016, B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia, Nutr Neurosci, 19, 461, 10.1179/1476830514Y.0000000136 · DOI
  50. Li, 2014, Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis, Curr Alzheimer Res, 11, 844
  51. Krause, 2015, Effect of vitamin intake on cognitive decline in older adults: evaluation of the evidence, J Nutr Health Aging, 19, 745, 10.1007/s12603-015-0539-3 · DOI
  52. Snitz, 2009, Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial, JAMA, 302, 2663, 10.1001/jama.2009.1913 · DOI · Paper page
  53. Naeini, 2014, The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial, Eur J Nutr, 53, 1255, 10.1007/s00394-013-0628-1 · DOI
  54. Singh, 2014, Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis, J Alzheimers Dis JAD, 39, 271, 10.3233/JAD-130830 · DOI · Paper page
  55. Kheirouri, 2021, MIND diet and cognitive performance in older adults: a systematic review, Crit Rev Food Sci Nutr, 1
  56. Hosking, 2019, MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study, Alzheimers Dement J Alzheimers Assoc, 15, 581, 10.1016/j.jalz.2018.12.011 · DOI · Paper page
  57. Nuzum, 2020, Potential benefits of physical activity in MCI and dementia, Behav Neurol, 2020, 7807856, 10.1155/2020/7807856 · DOI · Paper page
  58. Altschul, 2020, Playing analog games is associated with reduced declines in cognitive function: a 68-year longitudinal cohort study, J Gerontol Ser B, 75, 474, 10.1093/geronb/gbz149 · DOI
  59. Rai, 2018, Cognitive stimulation therapy for dementia, Clin Geriatr Med, 34, 653, 10.1016/j.cger.2018.06.010 · DOI
  60. Gomez-Soria, 2020, Cognitive stimulation program in mild cognitive impairment a randomized controlled trial, Dement Neuropsychol, 14, 110, 10.1590/1980-57642020dn14-020003 · DOI
  61. Cummings, 2019, Treatment combinations for Alzheimer’s disease: current and future pharmacotherapy options, J Alzheimers Dis JAD, 67, 779, 10.3233/JAD-180766 · DOI · Paper page
  62. Schmidt, 2015, EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease, Eur J Neurol, 22, 889, 10.1111/ene.12707 · DOI · Paper page
  63. Matsunaga, 2015, Combination therapy with cholinesterase inhibitors and memantine for Alzheimer’s disease: a systematic review and meta-analysis, Int J Neuropsychopharmacol, 18, pyu115, 10.1093/ijnp/pyu115 · DOI · Paper page
  64. Battle, 2021, Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis, Cochrane Database Syst Rev, 2, CD013306
  65. Sivasathiaseelan, 2019, Frontotemporal dementia: a clinical review, Semin Neurol, 39, 251, 10.1055/s-0039-1683379 · DOI
  66. Wang, 2015, Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis, J Neurol Neurosurg Psychiatr, 86, 135, 10.1136/jnnp-2014-307659 · DOI · Paper page
  67. Cheng, 2014, Mental and physical activities delay cognitive decline in older persons with dementia, Am J Geriatr Psychiatry, 22, 63, 10.1016/j.jagp.2013.01.060 · DOI · Paper page
  68. Hoffmann, 2016, Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial, J Alzheimers Dis JAD, 50, 443, 10.3233/JAD-150817 · DOI · Paper page
  69. Wang, 2007, Group reminiscence therapy for cognitive and affective function of demented elderly in Taiwan, Int J Geriatr Psychiatry, 22, 1235, 10.1002/gps.1821 · DOI · Paper page
  70. Lam, 2020, Effects of music therapy on patients with dementia-a systematic review, Geriatr Basel Switz, 5, E62, 10.3390/geriatrics5040062 · DOI
  71. Emblad, 2021, Creative art therapy as a non-pharmacological intervention for dementia: a systematic review, J Alzheimers Dis Rep, 5, 353
  72. Laakkonen, 2016, Effects of self-management groups for people with dementia and their spouses--randomized controlled trial, J Am Geriatr Soc, 64, 752, 10.1111/jgs.14055 · DOI · Paper page
  73. Widera, 2011, Finances in the older patient with cognitive impairment: “He didn’t want me to take over, JAMA, 305, 698, 10.1001/jama.2011.164 · DOI · Paper page
  74. Yunusa, 2019, Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis, JAMA Netw Open, 2, e190828, 10.1001/jamanetworkopen.2019.0828 · DOI · Paper page
  75. Tampi, 2020, Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm, Neurodegener Dis Manag, 10, 5, 10.2217/nmt-2019-0036 · DOI
  76. Chen, 2021, The psychopharmacology algorithm project at the harvard south shore program: an update on management of behavioral and psychological symptoms in dementia, Psychiatry Res, 295, 113641, 10.1016/j.psychres.2020.113641 · DOI
  77. Davies, 2018, Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia, J Psychopharmacol Oxf Engl, 32, 509, 10.1177/0269881117744996 · DOI · Paper page
  78. McCollum, 2020, Cognitive Impairment Evaluation and Management, Med Clin North Am, 104, 807, 10.1016/j.mcna.2020.06.007 · DOI

Cited by

See all 177

Metadata

Authors
Pérez Palmer, N., Trejo Ortega, B., & Joshi, P.
Venue
Psychiatric Clinics of North America
Publisher
Elsevier BV
Published
2022-12
Volume
45
Issue
4
Pages
639-661
ISSN
0193-953X (ISSN-L)
OpenAlex
W4306177210
Cited by
177
References
45
FWCI
19.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.